Concepedia
Statistics
Publications
28
Citations
4.9K
H-Index
22
Active since
1996
Affiliations
Amgen (United States)(Current)
University of California, Los Angeles
Ghent University Hospital
Howard Hughes Medical Institute
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Daniel J. Freeman is an author at Amgen (United States) specializing in medicine, oncology, and molecular oncology.
Publications per year
1996–2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Rafael G. Amado, Michael Wolf, Marc Peeters et al. · Journal of Clinical Oncology · 2008 · 3.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
Daniel J. Freeman, Andrew G. Li, Gang Wei et al. · Cancer Cell · 2003 · 515 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
Simon J. Dovedi, Matthew J. Elder, Chunning Yang et al. · Cancer Discovery · 2021 · 180 citations
Life Sciences, Immunology, Oncology +17
Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone
Daniel J. Freeman, Todd Juan, Maureen Reiner et al. · Clinical Colorectal Cancer · 2008 · 162 citations
Medicine, Cancer Biology, Oncology +13
PTEN Regulates Mdm2 Expression through the P1 Promoter
Chun-Ju Chang, Daniel J. Freeman, Hong Wu · Journal of Biological Chemistry · 2004 · 99 citations · Full text
Medicine, Molecular Biology, Molecular Genetics +10
1–5 of 28